Cargando…
Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis
As the world continues to grapple with the novel coronavirus [coronavirus disease 2019 (COVID-19)], many treatments have been proposed to help alleviate the symptoms and reduce the mortality rate. Hydroxychloroquine (HCQ) is an antimalarial drug that is typically used for several autoimmune, rheumat...
Autor principal: | Zeppieri, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520758/ https://www.ncbi.nlm.nih.gov/pubmed/37767541 http://dx.doi.org/10.5493/wjem.v13.i4.95 |
Ejemplares similares
-
Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis
por: Swarnakar, Raktim, et al.
Publicado: (2022) -
Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020) -
Can we use hydroxychloroquine to treat COVID-19 now?
por: Chen, Jun, et al.
Publicado: (2021) -
Complexities to consider when communicating risk of COVID-19
por: Skovdal, M., et al.
Publicado: (2020) -
Comment on: “Understanding required to consider AI applications to the field of ophthalmology”
por: Martins, Thiago Goncalves dos Santos
Publicado: (2022)